FDA approves Opana ER from Endo Pharma for Moderate to Severe Pain - 17-Dec-2011
The FDA has approved a new, harder-to-abuse formulation of Opana ER, the extended-release oxymorphone drug that is crush resistant from Endo Pharma for Moderate to Severe Pain. There have been generic versions of immediate release and extended release oxymorphone on the market for many years. The Endo Pharma version is distinguished by its "harder ro abuse " formulation which is patent protected until 2023.
Related News
FDA approves new product labelling for OxyContin Controlled Release(Purdue Pharma) for Pain Management
Moxduo (QRx Pharma) resubmitted to the FDA for approval for Pain control
Phase III results for ALO-02 (Pfizer) for moderate to severe Pain
BioDelivery Sciences Intl licenses BEMA buprenorphine to Endo Pharma for mild to severe Chronic Pain
Fasiglifam (Takeda) success in Phase III trial for treatment of Type 2 Diabetes
NICE recommends Betmiga (Astellas) for patients with Overactive Bladder
Three Phase III studies of Brintellix (Lundbeck/Takeda) for Depression meet primary endpoint
Results positive for Afinitor (Novartis) in BOLERO-3 study in HER2 positive Breast Cancer
Related Pain Management Information
Pain Management Clinical Guidelines
Early management of persistent non-specific low back pain
NICETherapeutic endoscopic division of epidural adhesions
NICEPain Management Clinical Trials
Craniosacral Therapy to Treat Chronic Low Back Pain
Clinicaltrials.gov 24 March 2013Efficacy Study of Cognitive Behavioural Treatment With Support on Communication and Information Technologies for the Management of Chronic Low Back Pain (POETS)
Clinicaltrials.gov 27 February 2013Pain Management Medical Journal Abstracts
The role of circulating sex hormones in menstrual cycle dependent modulation of pain-related brain activation
Pain 04 January 2013The pattern and time course of somatosensory changes in the human UVB sunburn model reveal the presence of peripheral and central sensitization
Pain 04 January 2013Pain Management Medical Apps
Pain Scale
Free
Doctot Pain
£3.99
Related Pain Management Drugs
- TRANSTEC TRANSDERMAL PATCH
- DEXTROPROPOXYPHENE (GENERIC)
- ANADIN IBUPROFEN
- MEPTID INJECTION
- DEPODUR (EXTENDED RELEASE MORPHINE SULFATE)
- ZYDOL SR TABS 100MG
- ACTIQ
- IMIGRAN RADIS TABLETS (50MG AND 100MG)
- OXYNORM 10 MG/ML SOLUTION FOR INJECTION OR INFUSION
- PARAMAX
- CAFERGOT
- PANADOL ACTIFAST
- MORPHINE SULPHATE SUPPOSITORIES
- ALMOGRAN 12.5 MG FILM-COATED TABLET
- OXYNORM 50 MG/ML, SOLUTION FOR INJECTION OR INFUSION
- NARAMIG (MIGRAINE)
- ZAMADOL INJECTION
- ZYDOL 50 MG SOLUBLE TABLETS
- CODIPAR 15MG/500MG EFFERVESCENT TABLETS
- NOBLIGAN TABLETS
- CO-CODAMOL EFF.
- OXYCONTIN 15 MG, 30 MG, 60 MG, 120MG PROLONGED RELEASE TABLETS
- MATRIFEN
- ALVEDON SUPPOSITORIES 60, 125, 250 MG
- CODIPAR CAPLETS 15/500
- PENTAZOCINE TABLETS BP 25MG
- ANADIN ULTRA DOUBLE STRENGTH 400MG CAPSULES/ANADIN LIQUIFAST 400MG CAPSULES
- MORCAP SR
- ZOMIG 5MG NASAL SPRAY
- DOMPERAMOL
- QUTENZA 179MG CUTANEOUS PATCH
- OXYNORM 5, 10, 20 MG
- MORPHINE SULPHATE INJECTION
- TRAMACET 37.5 MG/325 MG EFFERVESCENT TABLETS
- PARACODOL TABLETS
- SOLPADEINE MAX SOLUBLE TABLETS
- TILODOL SR 200 MG PROLONGED-RELEASE TABLETS
- CODEINE PHOSPHATE TABLETS 15MG
- LOPRESOR (MIGRAINE)
- ZYDOL SOLUTION FOR INJECTION
- ZAMADOL CAPSULES 50 MG
- XEFO
- OSMANIL 75MCG/HR TRANSDERMAL PATCHES
- DISPRIN DIRECT
- FLURBIPROFEN
- MEFENAMIC ACID (GENERIC)
- VEGANIN
- MST CONTINUS TABLETS 5 MG, 10 MG, 15 MG, 30 MG, 60 MG, 100 MG, 200 MG
- DIFLUNISAL (ANALGESIA) (GENERIC)
- MAXITRAM SR
- OXYNORM LIQUID 5 MG/5 ML ORAL SOLUTION AND OXYNORM CONCENTRATE 10 MG/ML ORAL SOLUTION
- TYLEX
- TRAMACET 37.5 MG/ 325 MG FILM-COATED TABLETS
- DICLOFENAC SODIUM 50MG TABLETS
- TILODOL SR 100 MG PROLONGED-RELEASE TABLETS
- REMEDEINE
- ZOMIG RAPIMELT 5 MG ORODISPERSIBLE TABLETS
- MIGRAMAX
- DIAMORPHINE HYDROCHLORIDE INJECTION BP 5MG
- DISPERSIBLE CO-CODAPRIN TABLETS BP 8/400MG
- ZAMADOL MELT 50 MG TABLETS
- CLOTAM RAPID
- ZYDOL 50 MG CAPSULES
- ZAMADOL 24HR 150 (200/300/400)MG TABLETS
- FROBEN TABLETS
- ZYDOL SR 50 MG TABLETS
- ELLIMANS UNIVERSAL MUSCLE RUB LOTION
- MST CONTINUS SUSPENSIONS 20, 30, 60, 100 AND 200 MG
- JUNIOR PARAPAED PARACETAMOL SUSPENSION 120MG/5ML
- ZOMIG 2.5MG TABS (MIGRAINE)
- OXYCONTIN TABLETS
- ABSTRAL SUBLINGUAL TABLETS
- CODEINE PHOSPHATE TABLETS 30MG
- PALLADONE CAPSULES
- TORADOL INJECTION
- DIHYDROCODEINE TABLETS BP 30MG
- BUTRANS 5, 10 AND 20UG/H TRANSDERMAL PATCH
- CYCLIMORPH 15 INJECTION
- SEVREDOL TABLETS 10MG, 20MG AND 50MG
- PALEXIA 50 MG FILM-COATED TABLETS
- DROMADOL SR
- TRAMADOL
- ZERIDAME SR PROLONGED RELEASE TABLETS
- ASPIRIN TABLETS BP 300MG
- PANADOL EXTRA ADVANCE 500 MG/65 MG TABLETS
- PETHIDINE
- ASPAV
- RELPAX 20MG AND 40MG FILM-COATED TABLETS
- EFFENTORA 100, 200, 400, 600 AND 800 MICROGRAMS BUCCAL TABLETS
- SOLPADOL
- DUROGESIC DTRANS 12/25/50/75/100 MCG/HR TRANSDERMAL PATCH
- DROMADOL XL
- CALPOL INFANT SUGAR FREE COLOUR FREE 120 MG/5 ML ORAL SUSPENSION
- TEMGESIC
- TILODOL SR 150 MG PROLONGED-RELEASE TABLETS
- VERSATIS 5% MEDICATED PLASTER
- MIDRID
- ZOMORPH
- IMIGRAN RECOVERY
- PALLADONE SR CAPSULES
- ZAMADOL SR CAPSULES 50MG, 100MG, 150MG, 200MG
- TRAMAKE
- MIGRALEVE
- PALFIUM
- MORAXEN
- ACUPAN
- MAXALT
- MXL
- MEDINOL PAEDIATRIC
- ORAMORPH
- NUBAIN
- FORTRAL
- MIGRANAL
- MIGRIL
- DHC CONTINUS PROLONGED RELEASE TABLETS 60MG, 90MG AND 120 MG
- SANOMIGRAN
Advert for Healthcare Professionals only